Assessment of relationship between serum vascular adhesion protein-1 (VAP-1) and gestational diabetes mellitus

References

• ACOG Committee on Practice Bulletins – Obstetrics. 2013. Practice Bulletin No 137: Gestational diabetes mellitus. Obstetrics and gynecology, 122, 406–416.
   PubMedGoogle Scholar
• Akbas, E.M., et al., 2014. Association of epicardial adipose tissue, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with diabetic nephropathy. International journal of clinical and experimental medicine, 7(7), 1794–1801.
   PubMed Web of Science ®Google Scholar
• Akinci, B., et al., 2011. Evaluation of postpartum carbohydrate intolerance and cardiovascular risk factors in women with gestational diabetes. Gynecological endocrinology, 27(5), 361–367.
   PubMed Web of Science ®Google Scholar
• Bellamy, L., et al., 2009. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. The lancet, 373(9677), 1773–1779.
   PubMed Web of Science ®Google Scholar
• Berggren, E.K., et al., 2015. First-trimester maternal serum C-reactive protein as a predictor of third-trimester impaired glucose tolerance. Reproductive sciences, 22(1), 90–93.
   PubMed Web of Science ®Google Scholar
• Brink, H.S., et al., 2016. The potential role of biomarkers in predicting gestational diabetes. Endocrine connections, 5(5), R26–34.
   PubMed Web of Science ®Google Scholar
• Butte, N.F., 2000. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. American journal of clinical nutrition, 71(5), 1256–1261.
   Web of Science ®Google Scholar
• Caglayan, E.K., et al., 2016. Is there any relationship between serum sirtuin-1 level and neutrophil–lymphocyte ratio in hyperemesis gravidarum? Journal of perinatal medicine, 44(3), 315–320.
   PubMed Web of Science ®Google Scholar
• Fröhlich, M., et al., 2000. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes care, 23(12), 1835–1839.
   PubMed Web of Science ®Google Scholar
• Galtier, F., 2010. Definition, epidemiology, risk factors. Diabetes and metabolism, 36(6), 628–651.
   PubMed Web of Science ®Google Scholar
• Georgiou, H.M., et al., 2008. Screening for biomarkers predictive of gestational diabetes mellitus. Acta diabetologica, 45(3), 157–165.
   PubMed Web of Science ®Google Scholar
• Harreiter, J., et al., 2014. Gestational diabetes mellitus and cardiovascular risk after pregnancy. Women's health, 10(1), 91–108.
   PubMedGoogle Scholar
• Hernandez-Guillamon, M., et al., 2012. VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke. Cerebrovascular diseases, 33(1), 55–63.
   PubMed Web of Science ®Google Scholar
• Hopmans, T.E., et al., 2015. Increased risk of type II diabetes mellitus and cardiovascular disease after gestational diabetes mellitus: a systematic review. Nederlands tijdschrift voor geneeskunde, 159, 8043.
   Google Scholar
• Hudzik, B., et al., 2015. Platelet-to-lymphocyte ratio is a marker of poor prognosis in patients with diabetes mellitus and ST-elevation myocardial infarction. Biomarkers in medicine, 9(3), 199–207.
   PubMed Web of Science ®Google Scholar
• Kirwan, J.P., et al., 2002. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes, 51(7), 2207–2213.
   PubMed Web of Science ®Google Scholar
• Kurtoglu, E., et al., 2015. May ratio of neutrophil to lymphocyte be useful in predicting the risk of developing preeclampsia? A pilot study. The journal of maternal-fetal & neonatal medicine, 28(1), 97–99.
   PubMed Web of Science ®Google Scholar
• Li, H.Y., et al., 2009. Change of serum vascular adhesion protein-1 after glucose loading correlates to carotid intima-medial thickness in nondiabetic subjects. Clinica chimica acta, 403(1–2), 97–101.
   PubMed Web of Science ®Google Scholar
• Li, H.Y., et al., 2011. Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes. Diabetes, 60(3), 993–999.
   PubMed Web of Science ®Google Scholar
• Li, H.Y., et al., 2016. Serum vascular adhesion protein-1 predicts end- stage renal disease in patients with type 2 diabetes. PLoS one, 11(2), e0147981. 0147981.
   PubMed Web of Science ®Google Scholar
• Lin, M.S., et al., 2008. Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease. Clinical biochemistry, 41(16–17), 1362–1367.
   PubMed Web of Science ®Google Scholar
• Mazzone, T., et al., 2008. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. The lancet, 371(9626), 1800–1809.
   PubMed Web of Science ®Google Scholar
• Merinen, M., et al., 2005. Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse. The American journal of pathology, 166(3), 793–800.
   PubMed Web of Science ®Google Scholar
• Metzger, B.E., et al., 2010. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes care, 33(7), e98–682.
   PubMed Web of Science ®Google Scholar
• National Institutes of Health Consensus Development Conference Panel, 2013. National Institutes of Health consensus development conference statement: diagnosing gestational diabetes mellitus, March 4–6, 2013. Obstet gynecol, 122, 358–369.
   PubMed Web of Science ®Google Scholar
• Qiu, C., et al., 2004. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus. Paediatric and perinatal epidemiology, 18(5), 377–384.
   PubMed Web of Science ®Google Scholar
• Quinlivan, J.A., et al., 2011. A randomised trial of a four-step multidisciplinary approach to the antenatal care of obese pregnant women. Australian and New Zealand journal of obstetrics and gynaecology, 51(2), 141–146.
   PubMed Web of Science ®Google Scholar
• Rota, S., et al., 2005. C-Reactive protein levels in non-obese pregnant women with gestational diabetes. The Tohoku journal of experimental medicine, 206(4), 341–345.
   PubMed Web of Science ®Google Scholar
• Sahbaz, A., et al., 2016. Comparison of the predictive value of plateletcrit with various other blood parameters in gestational diabetes development. Journal of obstetrics and gynaecology, 36(5), 589–593.
   PubMed Web of Science ®Google Scholar
• Salmi, M., et al., 1993. Induction and function of vascular adhesion protein-1 at sites of inflammation. Journal of experimental medicine, 178(6), 2255–2260.
   PubMed Web of Science ®Google Scholar
• Salmi, M., and Jalkanen, S., 2001. VAP-1: an adhesin and an enzyme. Trends in immunology, 22(4), 211–216.
   PubMed Web of Science ®Google Scholar
• Sargın, M.A., et al., 2016. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: are they useful for predicting gestational diabetes mellitus during pregnancy? Therapeutics and clinical risk management, 12, 657–665.
   PubMed Web of Science ®Google Scholar
• Tamayo, T., et al., 2014. Diabetes in Europe: an update. Diabetes research and clinical practice, 103(2), 206–217.
   PubMed Web of Science ®Google Scholar
• Van Assche, F.A., et al., 1992. Maternal diabetes and the effect for the offspring. Verhandelingen – Koninklijke academie voor geneeskunde van belgie, 54(2), 95–106.
   PubMedGoogle Scholar
• Wiznitzer, A., et al., 2009. Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. American journal of obstetrics and gynecology, 201, 481–488.
   Web of Science ®Google Scholar
• Wolf, M., et al., 2004. Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus. Diabetes care, 27(1), 21–27.
   PubMed Web of Science ®Google Scholar
• Yilmaz, H., et al., 2014. Benefits of the neutrophil-tolymphocyte ratio for the prediction of gestational diabetes mellitus in pregnant women. Experimental and clinical endocrinology and diabetes, 122(1), 39–43.
   PubMed Web of Science ®Google Scholar
• Yu, P.H., et al., 2003. Physiological and pathological implications of semicarbazide-sensitive amine oxidase. Biochimica et biophysica acta (bba) – proteins and proteomics, 1647(1-2), 193–199.
   PubMed Web of Science ®Google Scholar
• Yu, P.H., and Zuo, D.M., 1997. Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications. Diabetologia, 40(11), 1243–1250.
   PubMed Web of Science ®Google Scholar